Effect of dual inhibition of histone deacetylase and phosphatidylinositol-3 kinase in Philadelphia chromosome-positive leukemia cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s00280-019-04022-x.pdf
Reference29 articles.
1. Rowley JD (1973) Letter: a new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290–293. https://doi.org/10.1038/243290a0
2. Kantarjian HM, Talpaz M, Giles F, O’Brien S, Cortes J (2006) New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance. Ann Intern Med 145:913–923. https://doi.org/10.7326/0003-4819-145-12-200612190-00008
3. Kantarjian H, Sawyers C, Hochhaus A et al (2002) Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 346:645–652. https://doi.org/10.1056/NEJMoa011573
4. Saglio G, Kim DW, Issaragrisil S et al (2010) Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 362:2251–2259. https://doi.org/10.1056/NEJMoa0912614
5. Kantarjian H, Shah NP, Hochhaus A, Cortes J et al (2010) Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 362:2260–2270. https://doi.org/10.1056/NEJMoa1002315
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review;Biomedicines;2024-01-15
2. WEE1 and PARP-1 play critical roles in myelodysplastic syndrome and acute myeloid leukemia treatment;Cancer Cell International;2023-06-27
3. WEE1 and PARP-1 play critical roles in myelodysplastic syndrome (MDS): A novel approach to targeted MDS therapy;2023-01-04
4. Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions;Biomarker Research;2022-05-16
5. Effect of D-mannose on Philadelphia chromosome-positive leukemia cells;Cancer Biomarkers;2022-05-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3